CD274 and cancer: Vanderwalde et al. reported a lack of overlap of MSI and high TMB in several cancer types; specifically, MSI-H cases that were not TMB-H or PD-L1-positive occurred in significant percentages of ovarian (24%), neuroendocrine (57%), and cervical (33%) cancers [54].